Epigenetic Prognostic Assay Aims for Risk Stratification in Barrett’s Esophagus

An epigenetic prognostic assay may help personalize Barrett’s esophagus monitoring, according to a new ...

NOVEMBER 13, 2024

AGA Issues Updated Guideline on Endoscopic Eradication Therapy for BE

The AGA recently published a clinical practice guideline on endoscopic eradication therapy for Barrett’s ...

OCTOBER 1, 2024

Where Does Cryotherapy Belong in the Clinical Toolbox for Barrett’s Esophagus?

Cryotherapy can be considered as an alternative to radiofrequency ablation in the treatment of Barrett’s ...

APRIL 23, 2024

The Role of Biomarkers In the Management Of Barrett’s Esophagus

It is well established that selected patients with high-grade dysplasia (HGD)/esophageal adenocarcinoma (EAC) ...

OCTOBER 26, 2020

Personalized Surveillance for Barrett’s? Dutch Study Indicates a Possible Role

Personalizing a schedule of endoscopic surveillance for patients with low-grade Barrett’s esophagus based on ...

SEPTEMBER 23, 2020

Biomarker Test Accurately Predicts High-Risk Barrett’s Esophagus

A precision test that combines image analysis and biomarkers might change how clinicians monitor cancer risk in ...

SEPTEMBER 22, 2020

The Role of Biomarkers In the Management of Barrett’s Esophagus

We have yet to develop selection criteria to determine which patients with Barrett’s esophagus and either no ...

JULY 24, 2020

Basal Crypt Dysplasia In Barrett’s Esophagus

Research supports the concept that crypt dysplasia falls on the dysplasia pathway such that Barrett’s ...

SEPTEMBER 23, 2019